These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2006-001404-37 Cardiometabolic risk reduction by Rimonabant: the effectiveness in daily practice and its use not-yet-due
Ongoing 2006-004305-25 Residual effects of zopiclone 7.5 mg and temazepam 20 mg on cognition and actual driving performance in healthy elderly not-yet-due
Ongoing 2006-006611-68 Valsartan on top of standard therapy as a novel therapeutic strategy to treat cardiac dysfunction in patients with infammatory cardiomyopathies not-yet-due
Ongoing 2007-000885-20 Open label study to establish the efficacy of intravenous loading doses of Ibandronate 6 mg in patients with lung cancer and skeletal metastased experiencing moderate to severe bone pain. not-yet-due
Ongoing 2007-002154-28 Effects of insomnia and chronic use of hypnotics on driving performance not-yet-due
Ongoing 2007-002776-33 Treatment of superficial basal cell carcinoma by three non-invasive modalities: PDT vs. imiquimod vs. 5-fluorouracil not-yet-due
Ongoing 2007-004354-90 Effecten van aspirine op de plaatjesfunctie bij gezonde vrijwillige proefpersonen. not-yet-due
Not reported 2007-005402-53 Primary G-CSF prophylaxis during the first two cycles only or throughout all chemotherapy cycles in breast cancer patients at risk of febrile neutropenia 2009-12-15 due-trials
Ongoing 2007-005546-20 Systemic effects of mild renal insufficiency: the relation between forearm blood flow and ADMA. not-yet-due
Completed, but no date 2007-005929-30 Disruption of memory reconsolidation of alcohol-related memory associations by propanolol bad-data
Ongoing 2008-002003-75 Residual effects of zopiclone 7.5 mg on cognition and driving performance in insomnia patients chronically using hypnotics not-yet-due
Not reported 2008-008442-21 The effect of Spironolactone on memory performance under stressful circumstances. 2009-12-21 due-trials
Ongoing 2008-008900-42 The DIEP flap as a model of ischemia-reperfusion: an intervention study not-yet-due
Ongoing 2009-010608-27 A prospective cohort study to investigate the use of alfa V beta 3 integrin scintigraphic imaging with 99mTC-NC100692 to predict scar formation and heart failure after myocardial infarction in patient... not-yet-due
Completed, but no date 2009-012340-16 Effects of morning versus evening dose of hydroxyzine 50 mg on cognition in healthy subjects bad-data
Completed, but no date 2009-012740-17 Topical rapamycin to treat fibrofolliculomas in Birt-Hogg-Dubé syndrome. bad-data
Ongoing 2009-016446-50 Helping more smokers to quit by combining varenicline with counselling for smoking cessation. The COVACO randomized controlled trial. not-yet-due
Ongoing 2010-019381-90 an fMRI study on the effects of NicVAX and placebo on Central Nervous System activation and behaviour following a nicotine challenge not-yet-due
Ongoing 2010-020906-14 Randomized controlled trial of escitalopram versus placebo for patients with irritable bowel syndrome and panic disorder. not-yet-due
Ongoing 2010-021933-30 Effects of treated and untreated Allergic Rhinitis on Mood, Cognitive functions and Actual Driving Performance not-yet-due
Ongoing 2010-022025-15 Intradiscal Methylene Blue Injection Treatment for Chronic Discogenic Low back pain A prospective Clinical Series followed by a Randomised Placebo-Controlled Clinical Trial not-yet-due
Ongoing 2010-022410-11 Topical Diclofenac and Vitamin D3 to treat Basal Cell Carcinoma not-yet-due
Ongoing 2010-023861-23 The effect of P-glycoprotein transport inhibition on brainmechanisms of sedation and cognitive impairment following antihistamines in healthy volunteers not-yet-due
Completed, but no date 2010-024543-33 Can memantine prevent memory impairment induced by MDMA in humans bad-data
Listed as ongoing, but also has a completion date 2011-000300-18 REducing with MetfOrmin Vascular Adverse Lesions in T1DM (The REMOVAL study) 2017-02-17 bad-data
Ongoing 2011-001407-13 NasuMel® Gel - a Medical Grade Honey Product for the Treatment of Chronically Infected Radical Mastoid Cavities not-yet-due
Ongoing 2011-002070-23 Effects of roflumilast on cognition in healthy adults: a behaviour-EEG study not-yet-due
Ongoing 2011-003129-92 The Orange III trial: Optimised recovery with Movicol preoperatively within an enhanced recovery programme, a randomised controlled trial not-yet-due
Ongoing 2011-003727-35 Efficacy of the ClariVein device using liquid Polidocanol and foam for the treatment of great saphenous vein incompetence : a dose finding study. not-yet-due
Ongoing 2011-005809-77 Treatment of superficial basal cell carcinoma by topical photodynamic therapy with fractionated 5-aminolevulinic acid 20% versus two stage topical photodynamic therapy with methylaminolevulinate not-yet-due
Ongoing 2012-000432-26 Prospective study on the metabolic and linear growth effects of growh hormone treatment in children with Kabuki Syndrome not-yet-due
Ongoing 2012-001898-90 Effects of vernakalant and flecainide on atrial contractility in patients with atrial fibrillation not-yet-due
Ongoing 2012-002263-96 dabigatran and rivaroxaban: prediction of anticoagulant effect not-yet-due
Completed, but no date 2012-002935-27 Diagnostic value of novel MR imaging techniques for the primary staging and restaging of rectal cancer bad-data
Listed as ongoing, but also has a completion date 2012-004873-14 PREvention of Macular EDema after cataract surgery 2017-10-25 bad-data
Ongoing 2013-000179-34 More creative on cocaine? not-yet-due
Ongoing 2013-001260-34 TOPical Imiquimod treatment of high-grade Cervical intraepithelial neoplasia (TOPIC trial): a randomized controlled trial not-yet-due
Completed, but no date 2013-001511-70 Efficacy, safety and tolerability of lacosamide in patients with gain-of-function Nav1.7 mutations related small fiber neuropathy: bad-data
Ongoing 2013-002437-37 Effects on Intra-Coronary Attenuation using low iodine concentrations (240 mg, 300 mg and 370 mg iodine per ml) while maintaining identical IDR not-yet-due
Ongoing 2013-002512-27 The role of bile acids in human brown adipose tissue metabolism not-yet-due
Ongoing 2013-005439-26 Topical sinecatechins ointment in treatment of primary superficial Basal Cell Carcinoma: a double blind, randomized, placebo-controlled trial. not-yet-due
Ongoing 2014-001619-37 Contrast enhanced Diffusion-weighted Magnetic Resonance Imaging for detection of pathologic lymph nodes in ovarian cancer – a feasibility study. not-yet-due
Ongoing 2014-001733-86 The effect of L-arginine on brown adipose tissue metabolism in South Asian and white Caucasian subjects not-yet-due
Completed, but no date 2014-001801-42 Sensitivity of driving-related psychometric tests to the effects of two widely prescribed benzodiazepines: diazepam and oxazepam bad-data
Ongoing 2014-002970-36 Human intestinal ischemia and reperfusion not-yet-due
Ongoing 2014-002977-12 BRAIN KINETICS OF NEUROTRANSMISSION DURING THC INTOXICATION not-yet-due
Ongoing 2014-003479-52 Surgical excision versus combined therapy with Curettage and Imiquimod for the treatment of Nodular Basal Cell Carcinoma: an open, non-inferiority, randomized controlled trial not-yet-due
Ongoing 2014-003691-23 Topical Ingenol mebutate versus 5% 5-fluorouracil versus 5% Imiquimod versus photodynamic therapy in the treatment of actinic keratosis: a multi-center randomized efficacy and cost-effectiveness study... not-yet-due
Ongoing 2014-004899-35 Morphine for palliative treatment of refractory dyspnea in patients with advanced COPD: benefits and respiratory adverse effects not-yet-due
Completed, but no date 2014-005145-51 A randomised controlled multicenter trial comparing ultrasound-accelerated catheter-directed thrombolysis, combined with standard anticoagulant therapy, with standard anticoagulant therapy alone, for ... bad-data
Completed, but no date 2015-000578-37 The effect of Nandrolone Decanoate Injection and Leucine Supplementation on Muscle Loss During Immobilisation bad-data
Ongoing 2015-002624-31 Intravenous immunoglobulin therapy for small fiber neuropathy: a randomised, double-blind, placebo-controlled study on efficacy and safety. not-yet-due
Ongoing 2015-004846-25 Immunization against oxLDL in patients with lysosomal lipid diseases and associated metabolic disorders not-yet-due
Ongoing 2015-005467-16 Peppermint oil for the treatment of Irritable Bowel Syndrome: optimizing therapeutic strategies using targeted delivery not-yet-due
Completed, but no date 2016-000810-31 Impact of L-Carnitine infusion on Lipid induced Insulin resistance bad-data
Ongoing 2016-001512-38 Investigation of psychomotor performance to evaluate clinical impairment and pharmacokinetic aspects of methadone and buprenorphine: a double-blind placebo-controlled randomized trial not-yet-due
Ongoing 2016-001900-47 The effect of lidocaine infusion on ad libitum food intake and satiety in healthy volunteers not-yet-due
Ongoing 2016-002096-96 TOPical Imiquimod treatment of high-grade Cervical intraepithelial neoplasia, a multicenter, open-label, non-randomized, controlled study (TOPIC-3 study) not-yet-due
Ongoing 2016-002911-16 PET/MRI and plaque vulnerability A feasibility study of 18F-Flutemetamol in atherosclerosis not-yet-due
Ongoing 2017-002192-25 Neurotoxic adverse effects of morphine and oxycodone in continuous subcutaneous infusion for treatment of pain in terminal patients with diminished renal function: a Randomized Controlled Trial. not-yet-due
Ongoing 2017-002616-13 The effect of perioperative intravenous s-ketamine on acute and chronic postoperative craniotomy pain compared to placebo not-yet-due
Ongoing 2017-003124-73 Carnitine supplementation as a therapy to improve insulin sensitivity in Type 2 diabetic patients with low carnitine status not-yet-due
Ongoing 2017-003307-21 Tailored treatment of functional dyspepsia with nortriptyline: a multi-center double-blind placebo-controlled trial (TENDER) not-yet-due
Ongoing 2017-003365-99 The effects of ceasing opioid, benzodiazepine, or Z-hypnotic drug use on measures of driving performance and postural balance. not-yet-due